HappeningToo topic
Belimumab reports
Browse community reports connected to Belimumab. These reports can show that other people are describing similar experiences, but they do not prove that Belimumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
33 problems
Abdominal Pain Upper while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and abdominal pain upper appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and abdominal pain appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and alopecia appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and anxiety appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and back pain appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and chest discomfort appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and chills appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and cough appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and decreased appetite appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and diarrhea appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and dizziness appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and fatigue appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and feeling abnormal appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and headache appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and hives appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and insomnia appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and itching appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and malaise appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and migraine appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and muscle spasms appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and myalgia appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and nausea appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and oropharyngeal pain appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and pain appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and rash appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and shortness of breath appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and skin redness appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and sleepiness appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and swelling appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and vomiting appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and weakness appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and weight decreased appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Belimumab
FDA FAERS contains adverse-event reports in which Belimumab and weight increased appear together. This does not establish that Belimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →